The single nucleotide polymorphism rs700518 is an independent risk factor for metabolic syndrome and benign prostatic hyperplasia (MetS‐ BPH )-Reference-Cited by-同舟云学术

The single nucleotide polymorphism rs700518 is an independent risk factor for metabolic syndrome and benign prostatic hyperplasia (MetS‐ BPH )

Published:2018-06-05 Issue:4 Volume:6 Page:568-578
ISSN:2047-2919
Container-title:Andrology
language:en
Short-container-title:Andrology

Author:

Chen Z.P.¹²,Yan Y.¹,Chen C.J.²,Li M.²,Chen C.¹,Zhao S.C.¹,Song T.²,Liu T.²,Zou C.H.²,Xu Q.²,Li X.²

Affiliation:

1. Department of Urology Beijing Shijitan Hospital Capital Medical University Beijing China

2. Department of Urology Affiliated Hospital of Zunyi Medical College Zunyi China

Funder

National Natural Science Foundation of China

Beijing Municipal Science and Technology Commission

Publisher

Wiley

Subject

Urology,Endocrinology,Reproductive Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/andr.12498

Reference33 articles.

1. Metabolic Syndrome and Benign Prostatic Hyperplasia: Evidence of a Potential Relationship, Hypothesized Etiology, and Prevention

2. The association between polymorphisms in the CYP17 and 5alpha‐reductase (SRD5A2) genes and serum androgen concentrations in men;Allen NE;Cancer Epidemiol Biomarkers Prev,2001

3. Genotyping of Sex Hormone-Related Pathways in Benign and Malignant Human Prostate Tissues: Data of a Preliminary Study

4. BeaulieuM. (2003)Multiplexing the Homogeneous MassEXTEND Assay.Application Note (2003): Available at:http://www.sequenom.com/Assets/pdfs/appnotes/Multiplexing_hME_App_Note.pdf.

5. Association of polymorphisms in CYP19A1 and CYP3A4 genes with lower urinary tract symptoms, prostate volume, uroflow and PSA in a population-based sample

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The GG genotype of rs743572 in CYP17A1 gene regulating the decrease of T/E ratio can be an independent risk factor for MetS-BPH: a retrospective cohort study;World Journal of Urology;2024-07-24

2. Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese;Human Genomics;2024-05-22

3. Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese;2023-06-02

4. Genetic, Genomic, and Heritable Components of Benign Prostatic Hyperplasia;Current Bladder Dysfunction Reports;2023-04-20

5. The association between metabolic syndrome and benign prostatic hyperplasia: a systematic review and meta-analysis;The Aging Male;2020-06-02